MedTrace Logo

Atorvastatin in Moderate Active Crohns Disease

NCT00454545 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2007-10-22

No results posted yet for this study

Summary

Open pilot study to collect information regarding the effect of atorvastatin on patients with active Crohns disease.

Conditions

  • Crohns Disease

Interventions

DRUG

Atorvastatin

Sponsors & Collaborators

  • Skane University Hospital

    lead OTHER

Principal Investigators

  • Olof Grip, MD, PhD · Malmo University Hospital, Region Skåne

  • Anders Bredberg, MD, PhD · Malmo University Hospital, Region Skåne

  • Gunnel Bredberg, MD, PhD · Malmo University Hospital, Region Skåne

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Completion
2007-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00454545 on ClinicalTrials.gov